Alverate Tablet 60 mg is a medication primarily used to relieve symptoms associated with irritable bowel syndrome (IBS) and other functional gastrointestinal disorders. It is classified as an antispasmodic agent, which helps in alleviating smooth muscle spasms in the gastrointestinal tract.
Alverate Tablet 60 mg is used to:
| Brand Name | Alverate |
|---|---|
| Type | Tablet |
| Weight | 60 mg |
| Generic | Alverine Citrate |
| Manufacturer | Ibn Sina Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Alverate Tablet 60 mg works by relaxing the smooth muscles of the gastrointestinal tract. It acts on the smooth muscle cells by inhibiting the calcium influx necessary for muscle contraction. This reduces the spasms and pain associated with conditions like IBS.
The onset of action for Alverate Tablet 60 mg is typically within 30 to 60 minutes after oral administration. Symptom relief, including reduction in abdominal pain and discomfort, may be observed within this time frame. Full therapeutic effects are usually experienced after several days of consistent use.
Alverate Tablet 60 mg is well absorbed from the gastrointestinal tract after oral administration. The drug reaches peak plasma concentrations approximately 1 to 2 hours after ingestion. Food does not significantly affect the absorption of Alverate Tablet 60 mg.
Alverate Tablet 60 mg is metabolized in the liver, and its metabolites are excreted primarily in the urine. A small amount of the drug may be excreted in the feces. The rate of elimination can be influenced by liver function and renal health.
The recommended dosage of Alverate Tablet 60 mg is:
Alverate Tablet 60 mg should be taken orally with a glass of water. It is recommended to take the medication before meals to maximize its efficacy in reducing gastrointestinal symptoms. Consistent use as prescribed by a healthcare provider is important for achieving optimal results.
Common side effects of Alverate Tablet 60 mg include:
In cases of overdose or excessive use of Alverate Tablet 60 mg, symptoms may include severe gastrointestinal discomfort, nausea, and vomiting. Management involves discontinuing the medication and providing symptomatic and supportive care. Gastric lavage and activated charcoal may be considered in severe cases.
Precautions should be taken in patients with:
Alverate Tablet 60 mg may interact with:
Use Alverate Tablet 60 mg with caution in patients with:
Drug interactions with Alverate Tablet 60 mg are relatively few. However, potential interactions include:
There are no significant food interactions with Alverate Tablet 60 mg. It is generally recommended to take the medication before meals, but food intake does not substantially alter its efficacy.
Alverate Tablet 60 mg is classified as pregnancy category B. It should be used during pregnancy only if clearly needed. The drug's safety during pregnancy has not been fully established, so it should be used under medical supervision with a careful risk-benefit assessment.
Alverate Tablet 60 mg is excreted in breast milk in small amounts. While it is generally considered safe for use during lactation, caution is advised. Monitor for any potential adverse effects in the nursing infant, and consult a healthcare provider if concerns arise.
Acute overdose of Alverate Tablet 60 mg may result in severe gastrointestinal symptoms, including pain, nausea, and vomiting. Management involves discontinuing the medication and providing supportive care. In severe cases, medical intervention may be required.
Alverate Tablet 60 mg is contraindicated in patients with:
Alverate Tablet 60 mg should be used according to the prescribed dosage and administration instructions. Take the medication before meals, and follow the healthcare provider’s recommendations for duration and frequency of use. Adhere to the dosage instructions to avoid potential side effects and ensure effectiveness.
Store Alverate Tablet 60 mg at room temperature, between 20°C and 25°C (68°F and 77°F). Protect from light and moisture. Keep the medication tightly closed and out of reach of children.
The volume of distribution of Alverate Tablet 60 mg is not well-documented but is generally low due to its limited systemic absorption. Most of the drug remains within the gastrointestinal tract where it exerts its therapeutic effects.
The plasma half-life of Alverate Tablet 60 mg is approximately 2 to 4 hours. The drug's effects on smooth muscle relaxation last longer than its presence in the plasma due to its local action and metabolism.
Alverate Tablet 60 mg is primarily metabolized by the liver and cleared through the urine. The clearance rate may be affected by liver or renal impairment. Regular monitoring may be needed for patients with significant hepatic or renal conditions.
See in details version Alverate Tablet 60 mg also Alverate Tablet 60 mg in bangla
Prof. Dr. A. B. Siddiqui
Newborn, Adolescent & Child Diseases Specialist
Child Specialist Doctor in Rajshahi